{
    "organizations": [],
    "uuid": "2fb1c579041c3dc598997bc4cb6af0ad9f7e6e77",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-astrazeneca-says-aims-to-advance-c/brief-astrazeneca-says-aims-to-advance-clinical-practice-in-cv-risk-management-idUSFWN1QN035",
    "ord_in_thread": 0,
    "title": "BRIEF-Astrazeneca Says Aims To Advance Clinical Practice In CV Risk Management",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 5 (Reuters) - Astrazeneca Plc:\n* ASTRAZENECA AIMS TO ADVANCE CLINICAL PRACTICE IN CV RISK MANAGEMENT WITH NEW DATA AT ACC 2018 Further company coverage: (Reuters.Briefs@thomsonreuters.com)\n ",
    "published": "2018-03-05T15:25:00.000+02:00",
    "crawled": "2018-03-06T22:14:56.003+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "astrazeneca",
        "plc",
        "astrazeneca",
        "aim",
        "advance",
        "clinical",
        "practice",
        "cv",
        "risk",
        "management",
        "new",
        "data",
        "acc",
        "company",
        "coverage"
    ]
}